HCA Healthcare reported strong financial results for Q4 2020, driven by highly acute inpatient volumes and solid cost management. Revenues increased to $14.293 billion, and net income attributable to HCA Healthcare, Inc. totaled $1.426 billion, or $4.13 per diluted share.
Revenues totaled $14.293 billion.
Net income attributable to HCA Healthcare, Inc. totaled $1.426 billion, or $4.13 per diluted share.
Adjusted EBITDA totaled $3.118 billion.
Cash flows used in operating activities totaled $3.583 billion, including the return of over $6 billion in CARES Act funds.
The Company issued the following estimated guidance for 2021: Revenues $53.5 to $55.5 billion, Adjusted EBITDA $10.3 to $10.9 billion, EPS (diluted) $12.10 to $13.10 per diluted share and Capital Expenditures Approximately $3.7 billion.